研究论文(部分)
1. Lei Yu#, Xinglong Liu#, Xianmiao Ye#,…, Ling Chen*, Liqiang Feng*. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fcγ Receptor-dependent and -independent Pathways. mBio. 2021, 12: e03179-20.
2. Liqiang Feng#, Qian Wang#, Chao Shan#, …, Suhua Guan*, Zhiming Yuan*, Ling Chen*. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Nature Communications. 2020, 11(1): 4207
3. Ying Feng#, Changhua Yi#, Xinglong Liu#,…, Ling Chen*, Liqiang Feng*. Human desmoglein-2 and human CD46 mediate HAdV55 infection but human desmoglein-2 plays the major roles. Journal of Virology. 2020, 94(17): e00747-20
4. Xianmiao Ye#, Lijun Xiao#, Xuehua Zheng#,…, Ling Chen*, Liqiang Feng*. Seroprevalence of Neutralizing Antibodies to Human Adenovirus Type 4 and 7 in Healthy Populations from Southern China. Frontiers in Microbiology. 2018, 9:3040.
5. Xinglong Liu#, Linbing Qu#, Xianmiao Ye#, …, Liqiang Feng*, Ling Chen*. Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein. NPJ Vaccines. 2018, 3:29.
6. Yupeng Feng,…, Liqiang Feng*, Ling Chen*. An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques. Emerging Microbes & Infections. 2018. 7: 101.
7. Yiling Zhang#, Ying Feng#, …, Ling Chen*, Liqiang Feng*. Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma. Journal of Molecular Medicine. 2018, 96(3-4):249-263.
8. Xuehua Zheng#, Xia Rong#, …, Liqiang Feng*, Ling Chen*. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China. Emerging Microbes & Infections. 2017, 6: e43.
9. Feng Li#, Liqiang Feng#, …, Ling Chen*. Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in neuraminidase segment. Journal of Virology. 2010, 84(22):12075-12081.
发明专利(部分)
1. 一种复制缺陷型人55型腺病毒载体及其制备方法和应用;陈凌,冯立强;专利号: 201510179459。(授权)
2. 复制型重组人55型腺病毒载体及其制备方法和应用; 陈凌,冯立强,孙彩军,秦成峰;专利号:201410293359.2。(授权)
3. 一种复制缺陷型14型腺病毒载体及其制备方法和应用;陈凌,冯立强,李楚芳,孙西魁;申请号:201710116966.5。(实审)
4. 一种寨卡病毒疫苗及其制备方法;陈凌,冯立强;申请号:201711499584.1。(实审)
5. 一种复制缺陷型重组人7型腺病毒及其制备方法和应用; 陈凌,冯立强;申请号:201910761908.7。(实审)
6. 一种复制缺陷型重组人4型腺病毒及其制备方法和应用;陈凌,冯立强;申请号:201910761977.8。(实审)